Canada markets open in 3 hours 22 minutes

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.43-0.05 (-0.53%)
At close: 04:00PM EDT
9.26 -0.17 (-1.80%)
After hours: 07:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 557.00M
Enterprise Value 259.83M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)231.60
Price/Book (mrq)2.74
Enterprise Value/Revenue 121.98
Enterprise Value/EBITDA -1.02

Trading Information

Stock Price History

Beta (5Y Monthly) 0.25
52-Week Change 3-25.82%
S&P500 52-Week Change 321.33%
52 Week High 317.70
52 Week Low 33.81
50-Day Moving Average 310.08
200-Day Moving Average 38.53

Share Statistics

Avg Vol (3 month) 3294.21k
Avg Vol (10 day) 3406.29k
Shares Outstanding 533.57M
Implied Shares Outstanding 659.07M
Float 811.77M
% Held by Insiders 135.19%
% Held by Institutions 167.55%
Shares Short (Apr 15, 2024) 45.25M
Short Ratio (Apr 15, 2024) 423.48
Short % of Float (Apr 15, 2024) 433.68%
Short % of Shares Outstanding (Apr 15, 2024) 48.92%
Shares Short (prior month Mar 15, 2024) 44.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-9,722.43%

Management Effectiveness

Return on Assets (ttm)-34.91%
Return on Equity (ttm)-100.48%

Income Statement

Revenue (ttm)2.13M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)75.00%
Gross Profit (ttm)N/A
EBITDA -253.36M
Net Income Avi to Common (ttm)-246.42M
Diluted EPS (ttm)-4.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)337.68M
Total Cash Per Share (mrq)5.74
Total Debt (mrq)40.51M
Total Debt/Equity (mrq)19.93%
Current Ratio (mrq)8.18
Book Value Per Share (mrq)3.46

Cash Flow Statement

Operating Cash Flow (ttm)-192.23M
Levered Free Cash Flow (ttm)-121.96M